LDL in the circulation is well protected against oxidation by the highly efficient antioxidant defense mechanisms of human plasma. LDL oxidation contributing to atherosclerosis, therefore, has been hypothesized to take place in the interstitial fluid of the arterial wall. We investigated the antioxidant composition and the capacity to inhibit LDL oxidation of human suction blister interstitial fluid (SBIF), a suitable representative of interstitial fluid. We found that the concentrations in SBIF of the aqueous small-molecule antioxidants ascorbate and urate were, respectively, significantly higher (P < 0.05) and identical to plasma concentrations. In contrast, lipoprotein-associated lipids and lipid-soluble antioxidants (alpha-tocopherol, ubiquinol-10, lycopene, and beta-carotene) were present at only 8-23% of the concentrations in plasma. No lipid hydroperoxides could be detected ( < 5 nM) in either fluid. The capacity of serum and SBIF to protect LDL from oxidation was investigated in three metal ion-dependent systems: copper, iron, and murine macrophages in Ham's F-10 medium. In all three systems, addition of > or = 6% (vol/vol) of either serum or SBIF inhibited LDL oxidation by > 90%. The concentration that inhibited macrophage-mediated LDL oxidation by 50% was as low as 0.3% serum and 0.7% SBIF. The enzymatic or physical removal of ascorbate or urate and other low molecular weight components did not affect the ability of either fluid to prevent LDL oxidation, and the high molecular weight fraction was as protective as whole serum or SBIF. These data demonstrate that both serum and SBIF very effectively protect LDL from metal ion-dependent oxidation, most probably because of a cumulative metal-binding effect of several proteins. Our data suggest that LDL in the interstitial fluid of the arterial wall is very unlikely to get modified by metal ion-mediated oxidation.
A J Dabbagh, B Frei
Title and authors | Publication | Year |
---|---|---|
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
Abbott KL, Ali A, Reinfeld BI, Deik A, Subudhi S, Landis MD, Hongo RA, Young KL, Kunchok T, Nabel CS, Crowder KD, Kent JR, Madariaga ML, Jain RK, Beckermann KE, Lewis CA, Clish CB, Muir A, Rathmell WK, Rathmell J, Vander Heiden MG |
eLife | 2024 |
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability
Abbott KL, Ali A, Reinfeld BI, Deik A, Subudhi S, Landis MD, Hongo RA, Young KL, Kunchok T, Nabel CS, Crowder KD, Kent JR, Madariaga ML, Jain RK, Beckermann KE, Lewis CA, Clish CB, Muir A, Rathmell WK, Rathmell JC, Heiden MG |
2023 | |
Lysosome (Dys)function in Atherosclerosis—A Big Weight on the Shoulders of a Small Organelle
AR Marques, C Ramos, G Machado-Oliveira, OV Vieira |
Frontiers in Cell and Developmental Biology | 2021 |
Flexible Potentiometric Sensor System for Non-Invasive Determination of Antioxidant Activity of Human Skin: Application for Evaluating the Effectiveness of Phytocosmetic Products
AV Tarasov, EI Khamzina, MA Bukharinova, NY Stozhko |
Chemosensors | 2021 |
Risk Factors for Major Amputation on Hindfoot Ulcers in Hospitalized Diabetic Patients
KC Moon, KB Kim, SK Han, SH Jeong, ES Dhong |
Advances in Skin & Wound Care | 2019 |
The Mystery behind the Pineal Gland: Melatonin Affects the Metabolism of Cholesterol
K Karolczak, C Watala |
Oxidative medicine and cellular longevity | 2019 |
Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice
Y Wen, F Ahmad, Z Mohri, PD Weinberg, DS Leake |
Atherosclerosis | 2019 |
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed
F Ahmad, DS Leake |
Chemistry and Physics of Lipids | 2018 |
Lysosomal oxidation of LDL alters lysosomal pH, induces senescence, and increases secretion of pro-inflammatory cytokines in human macrophages
F Ahmad, DS Leake |
Journal of lipid research | 2018 |
Iron as a catalyst of human low-density lipoprotein oxidation: Critical factors involved in its oxidant properties
D Lapenna, G Ciofani, G Obletter |
Journal of Trace Elements in Medicine and Biology | 2017 |
The Role of Maternal Gestational Diabetes in Inducing Fetal Endothelial Dysfunction: DIABETES INDUCES ENDOTHELIAL DYSFUNCTION
SA Sultan, W Liu, Y Peng, W Roberts, D Whitelaw, AM Graham |
Journal of Cellular Physiology | 2015 |
Extracellular iron diminishes anticancer effects of vitamin C: An in vitro study
M Mojić, JB Pristov, D Maksimović-Ivanić, DR Jones, M Stanić, S Mijatović, I Spasojević |
Scientific Reports | 2014 |
Blistering time as a parameter for the strength of dermoepidermal adhesion: a systematic review and meta-analysis
LK Hatje, C Richter, U Blume-Peytavi, J Kottner |
The British journal of dermatology | 2014 |
Interstitial fluid lipoproteins:
J Lundberg, M Rudling, B Angelin |
Current Opinion in Lipidology | 2013 |
Oxidation of Low-Density Lipoprotein by Iron at Lysosomal pH: Implications for Atherosclerosis
L Satchell, DS Leake |
Biochemistry | 2012 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Actions of “antioxidants” in the protection against atherosclerosis
ME Lönn, JM Dennis, R Stocker |
Free radical biology & medicine | 2012 |
Association of total iron binding capacity with coronary artery disease
P Kang, T Liu, C Tian, Y Zhou, C Jia |
Clinica Chimica Acta | 2012 |
Altered oxidative state in schoolchildren with asthma and allergic rhinitis
E Bakkeheim, P Mowinckel, KH Carlsen, P Burney, KC Carlsen |
Pediatric Allergy and Immunology | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma
JP Kunes, KS Cordero-Koning, LH Lee, SM Lynch |
Nutrition Research | 2009 |
Function of scavenger receptor class A type I/II is not important for smooth muscle foam cell formation
B Luechtenborg, O Hofnagel, G Weissen-Plenz, NJ Severs, H Robenek |
European Journal of Cell Biology | 2008 |
Improved resistance to serum oxidation in Gilbert's syndrome: A mechanism for cardiovascular protection
AC Bulmer, JT Blanchfield, I Toth, RG Fassett, JS Coombes |
Atherosclerosis | 2008 |
Oximes as inhibitors of low density lipoprotein oxidation
RL Portella, RP Barcelos, AF de Bem, VS Carratu, L Bresolin, JB da Rocha, FA Soares |
Life Sciences | 2008 |
Serum oxidizability, total antioxidant status and albumin serum levels in patients with aneurysmal or arterial occlusive disease
I Delimaris, S Georgopoulos, C Kroupis, A Zachari, M Liberi, E Bastounis, A Dionyssiou-Asteriou |
Clinical Biochemistry | 2008 |
First evidence for an LDL- and HDL-associated nitratase activity that denitrates albumin-bound nitrotyrosine-Physiological consequences
CL Léger, E Torres-Rasgado, G Fouret, MA Carbonneau |
IUBMB Life | 2007 |
Atherosclerosis and Oxidant Stress: The End of the Road for Antioxidant Vitamin Treatment?
MJ Thomson, V Puntmann, JC Kaski |
Cardiovascular Drugs and Therapy | 2007 |
Peroxynitrite mild nitration of albumin and LDL–albumin complex naturally present in plasma and tyrosine nitration rate–albumin impairs LDL nitration
E Torres-Rasgado, G Fouret, MA Carbonneau, CL Leger |
Free Radical Research | 2007 |
Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system
P Parini, L Johansson, A Broijersen, B Angelin, M Rudling |
European Journal of Clinical Investigation | 2006 |
Levuglandins and Isolevuglandins: Stealthy Toxins of Oxidative Injury
RG Salomon |
Antioxidants & Redox Signaling | 2005 |
Lipid Peroxidation in the Presence of Albumin, Inhibitory and Prooxidative Effects
D Samocha-Bonet, S Gal, E Schnitzer, D Lichtenberg, I Pinchuk |
Free Radical Research | 2004 |
Role of Oxidative Modifications in Atherosclerosis
R Stocker, JF Keaney |
Physiological reviews | 2004 |
Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo
E Poliakov, ML Brennan, J Macpherson, R Zhang, W Sha, L Narine, RG Salomon, SL Hazen |
The FASEB Journal | 2003 |
Antioxidants
OA ab", SN a, SN ac" |
Antioxidants | 2003 |
Oxidative Stress and Disease: Significance or Triviality?
B Morrissey, A der Vliet, J Eiserich, C Cross |
Oxidative Stress and Disease: Significance or Triviality? | 2003 |
(−)-Epigallocatechin-(3)-gallate prevents oxidative damage in both the aqueous and lipid compartments of human plasma
G Aldini, KJ Yeum, M Carini, NI Krinsky, RM Russell |
Biochemical and Biophysical Research Communications | 2003 |
Free and Peptide-bound DOPA Can Inhibit Initiation of Low Density Lipoprotein Oxidation
M Exner, M Hermann, R Hofbauer, S Kapiotis, BM Gmeiner |
Free Radical Research | 2003 |
Human Neutrophils Oxidize Low-Density Lipoprotein by a Hypochlorous Acid- Dependent Mechanism: The Role of Vitamin C
AC Carr, B Frei |
Biological Chemistry | 2002 |
Aggregation of LDL with chondroitin-4-sulfate makes LDL oxidizable in the presence of water-soluble antioxidants
PM Abuja |
FEBS Letters | 2002 |
Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid
RA Patterson, ET Horsley, DS Leake |
Journal of lipid research | 2002 |
Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte
L Perrin-Cocon, F Coutant, S Agaugué, S Deforges, P André, V Lotteau |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
Handbook of Antioxidants
K Meissner, W Siems, O Sommerburg, M Leichsenring |
Handbook of Antioxidants | 2001 |
The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease
J Neuzil, C Weber, A Kontush |
Atherosclerosis | 2001 |
Ceruloplasmin as low-density lipoprotein oxidase: activation by ascorbate and dehydroascorbate
S Feichtenhofer, JS Fabjan, PM Abuja |
FEBS Letters | 2001 |
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
EA Podrez, M Febbraio, N Sheibani, D Schmitt, RL Silverstein, DP Hajjar, PA Cohen, WA Frazier, HF Hoff, SL Hazen |
Journal of Clinical Investigation | 2000 |
Ceruloplasmin and cardiovascular disease
PL Fox, B Mazumder, E Ehrenwald, CK Mukhopadhyay |
Free radical biology & medicine | 2000 |
Glucose enhancement of LDL oxidation is strictly metal ion dependent
HO Mowri, B Frei, JF Keaney |
Free radical biology & medicine | 2000 |
The Reductive Hotspot Hypothesis: An Update
AD de Grey |
Archives of Biochemistry and Biophysics | 2000 |
Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species: Reaction Pathways and Antioxidant Protection
AC Carr, MR McCall, B Frei |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Oxidative Stress and Vascular Disease
JF Keaney |
2000 | |
Effect of Pyrazinamide and Probenecid on Peritoneal Urate Transport Kinetics during Continuous Ambulatory Peritoneal Dialysis
S Spaia, I Magoula, G Tsapas, G Vayonas |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 2000 |
Transdermal extraction of analytes using low-frequency ultrasound
S Mitragotri, M Coleman, J Kost, R Langer |
Pharmaceutical Research | 2000 |
Urate attenuates oxidation of native low-density lipoprotein by hypochlorite and the subsequent lipoprotein-induced respiratory burst activities of polymorphonuclear leukocytes
S Kopprasch, K Richter, W Leonhardt, J Pietzsch, J Grässler |
Molecular and Cellular Biochemistry | 2000 |
Oxidation of heparin-treated low density lipoprotein by peroxidases
JE Upritchard, WH Sutherland |
Atherosclerosis | 1999 |
Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages
SC Whitman, SL Hazen, DB Miller, RA Hegele, JW Heinecke, MW Huff |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Antioxidant defenses in rat intestine and mesenteric lymph
D Mohr, Y Umeda, TG Redgrave, R Stocker |
Redox Report | 1999 |
Prooxidant and antioxidant properties of Trolox C, analogue of vitamin E, in oxidation of low-density lipoprotein
R Albertini, PM Abuja |
Free Radical Research | 1999 |
The Oxidation of Lipoproteins by Monocytes-Macrophages: BIOCHEMICAL AND BIOLOGICAL MECHANISMS
GM Chisolm, SL Hazen, PL Fox, MK Cathcart |
The Journal of biological chemistry | 1999 |
Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement
JM Upston, AC Terentis, R Stocker |
The FASEB Journal | 1999 |
Does vitamin C act as a pro-oxidant under physiological conditions?
A Carr, B Frei |
The FASEB Journal | 1999 |
Coexistence of Oxidized Lipids and α-Tocopherol in All Lipoprotein Density Fractions Isolated From Advanced Human Atherosclerotic Plaques
X Niu, V Zammit, JM Upston, RT Dean, R Stocker |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Leukocytes Utilize Myeloperoxidase-Generated Nitrating Intermediates as Physiological Catalysts for the Generation of Biologically Active Oxidized Lipids and Sterols in Serum
D Schmitt, Z Shen, R Zhang, SM Colles, W Wu, RG Salomon, Y Chen, GM Chisolm, SL Hazen |
Biochemistry | 1999 |
Association of high plasma antioxidant capacity with new lesion formation in carotid atherosclerosis: a prospective study
Reinisch, Kiechl, Mayr, Schratzberger, Dunzendorfer, Kahler, Buratti, Willeit, Wiedermann |
European Journal of Clinical Investigation | 1998 |
Atherosclerosis: cell biology and lipoproteins
KW Wahle |
Current Opinion in Lipidology | 1998 |
How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper
T Spranger |
Chemistry and Physics of Lipids | 1998 |
Human serum, cysteine and histidine inhibit the oxidation of low density lipoprotein less at acidic pH
RA Patterson, DS Leake |
FEBS Letters | 1998 |
Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations
TS Jackson, A Xu, JA Vita, JF Keaney |
Circulation research | 1998 |
Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE–/–) mice: apoE–/– mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis
J Neužil, JK Christison, E Iheanacho, JC Fragonas, V Zammit, NH Hunt, R Stocker |
Journal of lipid research | 1998 |
Mechanisms of lipid peroxidation in human blood plasma: a kinetic approach
B Karten, U Beisiegel, G Gercken, A Kontush |
Chemistry and Physics of Lipids | 1997 |
Whole plasma oxidation assay as a measure of lipoprotein oxidizability
A Kontush, T Spranger, A Reich, S Djahansouzi, B Karten, JH Braesen, B Finckh, A Kohlschütter, U Beisiegel |
BioFactors | 1997 |
Unexpected Dose Response of Copper Concentration on Lipoprotein Oxidation in Serum: Discovery of A Unique Peroxidase-Like Activity of Urate/Albumin in the Presence of High Copper Concentrations
JM Proudfoot, IB Puddey, LJ Beilin, R Stocker, KD Croft |
Free radical biology & medicine | 1997 |
Alpha-tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids
J Neuzil, PK Witting, R Stocker |
Proceedings of the National Academy of Sciences | 1997 |
Biochemistry and pathology of radical-mediated protein oxidation
RT Dean, S Fu, R Stocker, MJ Davies |
Biochemical Journal | 1997 |
-Tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids
J Neuzil, PK Witting, R Stocker |
Proceedings of the National Academy of Sciences | 1997 |
p -Hydroxyphenylacetaldehyde, the Major Product of l-Tyrosine Oxidation by the Myeloperoxidase-H 2 O 2 -Chloride System of Phagocytes, Covalently Modifies ε-Amino Groups of Protein Lysine Residues
SL Hazen, JP Gaut, FF Hsu, JR Crowley, A dAvignon, JW Heinecke |
The Journal of biological chemistry | 1997 |
Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?
DS Leake |
Atherosclerosis | 1997 |
Both Intracellular and Extracellular Vitamin C Inhibit Atherogenic Modification of LDL by Human Vascular Endothelial Cells
A Martin, B Frei |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Regulation of Local Angiotensin II Formation in the Human Heart in the Presence of Interstitial Fluid: Inhibition of Chymase by Protease Inhibitors of Interstitial Fluid and of Angiotensin-Converting Enzyme by Ang-(1-9) Formed by Heart Carboxypeptidase A–Like Activity
JO Kokkonen, J Saarinen, PT Kovanen |
Circulation | 1997 |
Effect of Iron Overload and Iron Deficiency on Atherosclerosis in the Hypercholesterolemic Rabbit
AJ Dabbagh, GT Shwaery, JF Keaney, B Frei |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
RRR-alpha-tocopherol can be substituted for by Trolox in determination of kinetic parameters of LDL oxidizability by copper
AR Bergmann, P Ramos, H Esterbauer, BM Winklhofer-Roob |
Journal of lipid research | 1997 |
Ceruloplasmin Enhances Smooth Muscle Cell- and Endothelial Cell-mediated Low Density Lipoprotein Oxidation by a Superoxide-dependent Mechanism
CK Mukhopadhyay, E Ehrenwald, PL Fox |
The Journal of biological chemistry | 1996 |
Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum
JM Hodgson, KD Croft, IB Puddey, TA Mori, LJ Beilin |
The Journal of Nutritional Biochemistry | 1996 |
Oxidative modification and antioxidant protection of human low density lipoprotein at high and low oxygen partial pressures
A Hatta, B Frei |
Journal of lipid research | 1995 |
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal |
Advances in Pharmacology | 1994 |